Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
62,625.79 -1,884.56 (-2.92%) CMC Crypto 200
1,307.47 -89.07 (-6.38%)
Catalyst Pharmaceuticals, Inc. (CPRX)
After hours:
| Previous close | 14.68 |
| Open | 14.84 |
| Bid | 14.83 x 200 |
| Ask | 14.92 x 200 |
| Day's range | 14.70 - 15.06 |
| 52-week range | 11.09 - 17.77 |
| Volume | |
| Avg. volume | 1,335,144 |
| Market cap | 1.757B |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | 23.63 |
| EPS (TTM) | 0.63 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 26.71 |
GlobeNewswireCatalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
The Company will Host a Conference Call and Webcast on Thursday, May 9, 2024, at 8:30 AM ETCORAL GABLES, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that it will release its first quarter 2024 financial results after the market close
Simply Wall St.Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who own 65% of the company
Key Insights Given the large stake in the stock by institutions, Catalyst Pharmaceuticals' stock price might be...
Insider MonkeyJim Cramer’s 10 Favorite Healthcare Stock Picks in 2024
In this article, we will take a detailed look at Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024. For a quick overview of such stocks, read our article Jim Cramer’s 5 Favorite Healthcare Stock Picks in 2024. Jim Cramer kicked off 2024 with a positive note for the healthcare sector, saying in a program in January that the […]
